Skip to main content
13 Mar | 2023

The BBRC hosts the sixth edition of the Workshop on biomarkers for neurodegenerative diseases

The event, organized together with University College London and the University of Gothenburg, is aimed at PhD students and will take place between the 15th and the 19th of May.

10 Mar | 2023

Arcadi Navarro receives the Award of Honor of the Telecommunications and IT Night

The Telecommunications Night Award of Honor distinguishes a public or private personality with a wide and distinguished professional career related to Electronics, Information and Communication Technologies or Audiovisual in the technical, academic, business or institutional field within the State.

22 Feb | 2023

28 European institutions establish new guidelines to prevent Alzheimer's

An international initiative with the participation of the BBRC has published a protocol for the creation of Brain Health Services, intended for the attention of people without cognitive impairment who wish to preserve or improve their memory.

11 Feb | 2023

We join the International Day of Women and Girls in Science

Three BBRC professionals give us their vision of women in the scientific field

02 Feb | 2023

Success of the first call for Pasqual Maragall Researchers Program scholarships with more than 60 applications received

Requests have been received from research centers in eight autonomous communities in Spain. Among the collaborators, a total of 17 researchers come from international centers.

18 Jan | 2023

BBRC's AlfaSleep project publishes an observational study protocol on sleep quality and its relationship with Alzheimer's disease

The research has the voluntary participation of two hundred people without cognitive impairment from the ALFA+ Study, with the support of the "la Caixa" Foundation

19 Dec | 2022

We found that a genetic predisposition to longer telomeres could have a protective effect against Alzheimer's

The investigations have been led by the Barcelonaβeta Brain Research Center (BBRC) and have included participants without cognitive alterations from the ALFA Study, with the support of the ”la Caixa” Foundation

05 Dec | 2022

Dr. Josep Maria Argimon, appointed Director of the Scientific Infrastructure of the Barcelonaβeta Brain Research Center

The Research Center of the Pasqual Maragall Foundation incorporates Dr. Argimon to lead the development and management of its research infrastructures, studies and cohorts.

30 Nov | 2022

A new research drug against Alzheimer's confirms its positive results during CTAD

The results, published in The New England Journal of Medicine, confirm that lecanemab slows cognitive decline by 27% in patients in the early stages of Alzheimer's disease.